GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+6.2%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$211M
AUM Growth
+$211M
(+72%)
Cap. Flow
+$86.7M
Cap. Flow
% of AUM
40.99%
Top 10 Holdings %
Top 10 Hldgs %
41.51%
Holding
78
New
28
Increased
12
Reduced
5
Closed
21
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$8.48M |
| 2 |
CONMED
CNMD
|
$8.35M |
| 3 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$8.29M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$7.38M |
| 5 |
BLUE
bluebird bio
BLUE
|
$7.36M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$6.43M |
| 2 |
Pacific Biosciences
PACB
|
$5.95M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$5.68M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$5.13M |
| 5 |
iShares US Healthcare Providers ETF
IHF
|
$4.82M |
Sector Composition
| 1 | Healthcare | 91.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Acadia Pharmaceuticals
ACAD
$4.34B
| – | – |
-75,000
| Closed | -$2.1M |
|
77
AbbVie
ABBV
$374B
| – | – |
0
| – | – |
|
|
78
Agios Pharmaceuticals
AGIO
$2.36B
| – | – |
-140,000
| Closed | -$5.68M |
|